Company / Capital Expenditures
IRADIMED CORP Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$7.8M
FY2025
5-year range
$368.3K / $8.0M
FY2021-FY2025
Trend
-3.0%
vs FY2024
Sector context
#120 of 151
Health Care
What the data says
IRADIMED CORP's capital expenditures of $8M is lower than 79% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $298,723 in FY2017 to $8M in FY2024.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +77.3%.
Improved from $7M to $8M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +152.5%
- 5-Year CAGR
- +77.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 151This company $7.8M Sector average $271.7M
▼
-97.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +77.3%, indicating consistent growth.
- In FY2025, capital expenditures decreased 3.0% year-over-year.
- Ranks #120 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.8M | -3.0% |
| FY2024 | $8.0M | +7.6% |
| FY2023 | $7.4M | +1442.6% |
| FY2022 | $482.3K | +31.0% |
| FY2021 | $368.3K | -16.9% |
| FY2020 | $443.0K | +20.3% |
| FY2019 | $368.3K | -52.8% |
| FY2018 | $780.8K | +161.4% |
| FY2017 | $298.7K | -48.8% |
| FY2016 | $584.0K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026